The Valley Desk

NCT06100276 · Interventional trial

Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions Amyotrophic Lateral Sclerosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov